🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
This study will be a phase I, open label, two arm, fixed sequence crossover...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05
Trial ID
NCT01231542
Treatments Being Tested
This study evaluated the potential drug-drug interactions between dolutegra...
Status
Terminated
Location
University of California HIV/AIDS CRS
Start Date
2021-02-27
Trial ID
NCT04272242
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
The purpose of this trial is to assess the non-inferior antiviral activity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-19
Trial ID
NCT01227824
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
HIV and hepatitis C virus (HCV) infection are diseases that share the same ...
Status
Terminated
Location
Alabama CRS
Start Date
2015-09-16
Trial ID
NCT02194998
Treatments Being Tested
Dolutegravir (DTG, GSK1349572 is an integrase inhibitor that is currently i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-12
Trial ID
NCT01498861
Treatments Being Tested
Study ING116529 is a multicenter, randomized, study with an initial 7 day p...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-18
Trial ID
NCT01568892
Treatments Being Tested
ING114916 is an open-label, multi-center, expanded access (EAP) study...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-06-14
Trial ID
NCT01536873
Treatments Being Tested